Ruiz-Galindo E, Arenas-Huertero F, Ramón-Gallegos E
Lab. de Citopatología Ambiental, Escuela Nacional de Ciencias Biológicas del Instituto Politécnico Nacional, Universidad Nacional Autónoma de México, México, DF, México.
J Exp Clin Cancer Res. 2007 Jun;26(2):195-200.
Photodynamic therapy (PDT), using protoporphyrin IX (PpIX) as a natural photosensitizer, may be a viable alternative therapy of retinoblastoma. In order to evaluate the potential value of PpIX, the expression profiles of genes involved in heme biosynthesis in human retinoblastoma WERI-Rb-1 and Y79 cells were analyzed by reverse transcriptase-polymerase chain reaction (RT-PCR). Expression levels were highest in protoporphyrinogen oxidase (PPOX), uroporphyrinogen synthase and aminolevulinic acid synthase. Ferrochelatase expression showed a reduction compared to PPOX. PpIX levels were 15- and 18-fold higher in WERI-Rb-1 and Y79 cells, respectively, following induction by delta-aminolevulinic acid. PDT may thus be a promising treatment in vitro, at least in these two retinoblastoma cell lines.
以原卟啉 IX(PpIX)作为天然光敏剂的光动力疗法(PDT)可能是视网膜母细胞瘤的一种可行替代疗法。为了评估 PpIX 的潜在价值,通过逆转录聚合酶链反应(RT-PCR)分析了人视网膜母细胞瘤 WERI-Rb-1 和 Y79 细胞中参与血红素生物合成的基因表达谱。原卟啉原氧化酶(PPOX)、尿卟啉原合酶和δ-氨基乙酰丙酸合酶的表达水平最高。与 PPOX 相比,亚铁螯合酶的表达有所降低。在δ-氨基乙酰丙酸诱导后,WERI-Rb-1 和 Y79 细胞中的 PpIX 水平分别高出 15 倍和 18 倍。因此,至少在这两种视网膜母细胞瘤细胞系中,PDT 在体外可能是一种有前景的治疗方法。